MedTrace Logo

Study of U101 for Bladder Pain and/or Urgency

NCT00256542 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2006-09-29

No results posted yet for this study

Summary

The purpose of this study is to determine whether intravesical U101 (alkalinized lidocaine-heparin) treatment reduces the symptoms of pelvic pain and/or urgency of bladder origin.

Conditions

  • Pelvic Pain
  • Interstitial Cystitis
  • Bladder Diseases

Interventions

DRUG

Alkalinized Lidocaine-Heparin

Sponsors & Collaborators

  • Urigen

    lead INDUSTRY

Principal Investigators

  • C. Lowell Parsons, MD · UCSD

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-01-31
Completion
2006-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00256542 on ClinicalTrials.gov